Literature DB >> 22940071

Type VII collagen deficiency causes defective tooth enamel formation due to poor differentiation of ameloblasts.

Hiroko Umemoto1, Masashi Akiyama, Takanori Domon, Toshifumi Nomura, Satoru Shinkuma, Kei Ito, Takuya Asaka, Daisuke Sawamura, Jouni Uitto, Motohiro Uo, Yoshimasa Kitagawa, Hiroshi Shimizu.   

Abstract

Recessive dystrophic epidermolysis bullosa (RDEB) is caused by mutations in the gene encoding type VII collagen (COL7), a major component of anchoring fibrils in the epidermal basement membrane zone. Patients with RDEB present a low oral hygiene index and prevalent tooth abnormalities with caries. We examined the tooth enamel structure of an RDEB patient by scanning electron microscopy. It showed irregular enamel prisms, indicating structural enamel defects. To elucidate the pathomechanisms of enamel defects due to COL7 deficiency, we investigated tooth formation in Col7a1(-/-) and COL7-rescued humanized mice that we have established. The enamel from Col7a1(-/-) mice had normal surface structure. The enamel calcification and chemical composition of Col7a1(-/-) mice were similar to those of the wild type. However, transverse sections of teeth from the Col7a1(-/-) mice showed irregular enamel prisms, which were also observed in the RDEB patient. Furthermore, the Col7a1(-/-) mice teeth had poorly differentiated ameloblasts, lacking normal enamel protein-secreting Tomes' processes, and showed reduced mRNA expression of amelogenin and other enamel-related molecules. These enamel abnormalities were corrected in the COL7-rescued humanized mice expressing a human COL7A1 transgene. These findings suggest that COL7 regulates ameloblast differentiation and is essential for the formation of Tomes' processes. Collectively, COL7 deficiency is thought to disrupt epithelial-mesenchymal interactions, leading to defective ameloblast differentiation and enamel malformation in RDEB patients.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22940071     DOI: 10.1016/j.ajpath.2012.07.018

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  7 in total

1.  Enamel organic matrix: potential structural role in enamel and relationship to residual basement membrane constituents at the dentin enamel junction.

Authors:  Jacob D McGuire; Mary P Walker; Vladimir Dusevich; Yong Wang; Jeff P Gorski
Journal:  Connect Tissue Res       Date:  2014-08       Impact factor: 3.417

2.  Impaired lymphoid extracellular matrix impedes antibacterial immunity in epidermolysis bullosa.

Authors:  Alexander Nyström; Olivier Bornert; Tobias Kühl; Christine Gretzmeier; Kerstin Thriene; Jörn Dengjel; Andrea Pfister-Wartha; Dimitra Kiritsi; Leena Bruckner-Tuderman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-05       Impact factor: 11.205

3.  Type IV collagen is a novel DEJ biomarker that is reduced by radiotherapy.

Authors:  J D McGuire; J P Gorski; V Dusevich; Y Wang; M P Walker
Journal:  J Dent Res       Date:  2014-08-21       Impact factor: 6.116

4.  Type VII collagen is enriched in the enamel organic matrix associated with the dentin-enamel junction of mature human teeth.

Authors:  Jacob D McGuire; Mary P Walker; Ahmad Mousa; Yong Wang; Jeff P Gorski
Journal:  Bone       Date:  2014-03-01       Impact factor: 4.398

5.  The Role of Discoidin Domain Receptor 2 in Tooth Development.

Authors:  F F Mohamed; C Ge; A Binrayes; R T Franceschi
Journal:  J Dent Res       Date:  2019-12-23       Impact factor: 6.116

6.  Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita.

Authors:  Ralf J Ludwig
Journal:  ISRN Dermatol       Date:  2013-07-15

7.  Detection of Type VII collagen in odontogenic keratocyst: An immunohistochemical study.

Authors:  Jochima-Eudora Cota; Anita Spadigam; Anita Dhupar
Journal:  J Clin Exp Dent       Date:  2019-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.